Skip to main content

Table 2 Clinical features of the pediatric ALL cases for bone marrow samples

From: NF-kappa B mediated Up-regulation of CCCTC-binding factor in pediatric acute lymphoblastic leukemia

  No. Sex Age of diagnosis (years) WBC in PB at newly diagnosis (×109/L) Immunotype Percentage of blast cells in BM at newly diagnosis (%) Cytogenetic abnormality Fusion gene Prognosis
Unpaired samples 1 F 10 5.2 Common B cell 89.5 - - Remission
2 M 5 10.5 T cell 98 - - Remission
3 M 2 24 Common B cell 99.5 - - Remission
4 F 7 4.9 Common B cell 99.5 - - Remission
5 M 6 79 Common B cell 93 - - Remission
6 M 6 4.9 Common B cell 96 - - Remission
7 F 10 6.6 Common B cell 96 - - Remission
  8 M 5 17.4 Common B cell 90.5 t(12;21) TEL-AML1 Remission
Paired samples 9 F 3 101 Common B cell 99 t(12;21) TEL-AML1 Remission
10 M 4 84 Common B cell 95 t(12;21) TEL-AML1 Remission
11 F 8 113 Pro-B cell 97.5 - - Remission
12 M 2 17 Common B cell 89.5 - - Remission
13 M 7 2.4 Common B cell 99 - - Remission
14 F 2 6.8 Common B cell 98 - HOX11 Remission
15 M 6 18.4 Common B cell 92.5 t(9;22) BCR-ABL Remission
16 F 2 6 Common B cell 94.5 t(12;21) TEL-AML1 Remission
17 M 5 68.2 Common B cell 96 t(1;19) E2A-PBX1 Remission
18 M 7 6.9 Common B cell 95 t(1;19) E2A-PBX1 Remission
19 F 8 113 Common B cell 99 t(1;19) E2A-PBX1 Remission
20 F 3 39.3 Common B cell 96 t(12;21) TEL-AML1 Remission
21 M 3 65 Pre-B cell 97.5 t(12;21) TEL-AML1 Remission
22 F 3 14 Common B cell 92.5 t(12;21) TEL-AML1 Remission
23 M 5 5.4 Common B cell 88.5 t(12;21) TEL-AML1 Remission
  24 M 2 10 Common B cell 87.5 t(12;21) TEL-AML1 Remission
Relapsed samples 25 M 0.58 (7 months) 120 Common B cell 91.5   MLL Dead
26 M 15 24.5 Common B cell 96 - - Dead
27 M 10 10.3 Common B cell 97.5 - - Dead
  28 M 9 14 Common B cell 98 - - Dead
  1. WBC, white blood cell; PB, peripheral blood; BM, bone marrow.